Xenetic Biosciences, Inc.
XBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534525
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $442.8K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding XBIO, Q2 2026
No superinvestor reported holding XBIO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Xenetic Biosciences, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Xenetic Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 117,440 | $341.8K | 0.00% | −20,000−14.6% | Reduced |
| Geode Capital Management, LLC | 17,423 | $50.7K | 0.00% | −4,018−18.7% | Reduced |
| Vanguard Capital Management LLC | 12,681 | $36.9K | 0.00% | +5,950+88.4% | Added |
| JTC Employer Solutions Trusteee Ltd | 2,700 | $8.00K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1,000 | $2.91K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 696 | $2.02K | 0.00% | −110−13.6% | Reduced |
| Morgan Stanley | 150 | $437 | 0.00% | +150 | New |
| Darwin Advisors, LLC | 2 | $5 | 0.00% | 00.0% | Unchanged |